scholarly article | Q13442814 |
P50 | author | Chin Kook Rhee | Q40351138 |
Kwang Ha Yoo | Q85265642 | ||
Ki-Suck Jung | Q85360203 | ||
P2093 | author name string | Yu-Il Kim | |
Tae-Ok Kim | |||
Sung-Chul Lim | |||
Hong-Joon Shin | |||
Seong-Yong Lim | |||
Won-Yeon Lee | |||
Seoung-Ju Park | |||
Seung-Won Ra | |||
P2860 | cites work | Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary | Q29614970 |
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease | Q29618681 | ||
Overtreatment of COPD with inhaled corticosteroids--implications for safety and costs: cross-sectional observational study | Q35032254 | ||
Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort. | Q36735833 | ||
A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD. | Q38753716 | ||
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. | Q40753167 | ||
How far is real life from COPD therapy guidelines? An Italian observational study | Q43850539 | ||
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide | Q46966092 | ||
Adherence to a COPD treatment guideline among patients in Hong Kong | Q47100661 | ||
Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA). | Q47849746 | ||
Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort | Q47936696 | ||
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary | Q47984024 | ||
Adherence to Current COPD Guidelines in Turkey | Q48907835 | ||
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. | Q51533361 | ||
Blood eosinophils as a marker of response to inhaled corticosteroids in COPD. | Q51544184 | ||
Revised (2018) COPD Clinical Practice Guideline of the Korean Academy of Tuberculosis and Respiratory Disease: A Summary | Q57210495 | ||
Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study | Q58381887 | ||
Adherence to GOLD guidelines in real-life COPD management in the Puglia region of Italy | Q58777676 | ||
[COPD routine management in France: are guidelines used in clinical practice?] | Q82856463 | ||
Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS | Q91450903 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | South Korea | Q884 |
P304 | page(s) | 47-53 | |
P577 | publication date | 2019-01-25 | |
P1433 | published in | Chonnam Medical Journal | Q26842647 |
P1476 | title | Adherence to the GOLD Guideline in COPD Management of South Korea: Findings from KOCOSS Study 2011-2018 | |
P478 | volume | 55 |
Q90450879 | Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD) | cites work | P2860 |
Search more.